Mahsa Etminan Heidari

Mahsa Etminan Heidari is an experienced medical professional currently serving as Associate Medical Director at Sobi - Swedish Orphan Biovitrum AB (publ) since August 2018, where Mahsa is accountable for country-based medical responsibilities and leads regional medical initiatives for designated products. Prior experience includes roles at AstraZeneca as a Strategic Account Manager in Oncology, managing accounts and identifying regional business opportunities, and at Novartis in various capacities within Oncology, focusing on brand development and tender management. Mahsa began a career in pharmacy at Apoteket AB, offering patient advice and later worked in security and education roles. Academic qualifications include a Master of Science in Pharmacy from Uppsala University and participation in leadership development programs.